EUVIMEDEUVIMED entdecken
Open Access

Pre-Clinical Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine Formulated with Aluminum Hydroxide Adjuvant

Douglas M Watts, Beth-Ann G Coller, Amelia P Da Rosa Travassos, Patrick Newman, Ashley Grant, Timothy Martyak, Junhui Jia, David E Clements, Michael M Lieberman

The American Journal of Tropical Medicine and Hygiene · 05.08.2026 · 115 (2) · 372-382

DOI: 10.4269/ajtmh.26-0133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 05.08.2026. Verfasst von Douglas M Watts und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Aluminum Hydroxide, West Nile Fever, West Nile virus, West Nile Virus Vaccines. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

West Nile Virus (WNV) is endemic throughout the world and is a leading cause of mosquito-borne severe and/or fatal encephalitic disease. Although several promising WNV vaccines have been developed, none have been approved for human use. Studies were conducted to evaluate the immunogenicity, protective efficacy, and safety of a recombinant subunit WNV candidate vaccine (WN-80E) formulated with aluminum hydroxide (Alhydrogel™) adjuvant and/or in combination with a semi-synthetic saponin (GPI-0100) adjuvant in mice and hamsters, and for toxicology, immunogenicity and safety in rabbits. Adult mice and hamsters were immunized twice via the intramuscular (IM) route 3 to 4 weeks apart with escalating doses of WN-80E adsorbed to Alhydrogel™. Mice were also immunized with WN-80E in combination with the GPI-0100 adjuvant. All animals were subsequently challenged with a lethal dose of virulent WNV. The rabbits received four IM immunizations 3 weeks apart with WN-80E/Alhydrogel™ that was compared to WN-80E/Alhydrogel™ plus various amounts of GPI-0100. The results of immunogenicity and challenge experiments demonstrated that all WN-80E vaccine formulations with Alhydrogel™ with or without GPI-0100 were immunogenic and afforded complete protection to mice and hamsters against morbidity and mortality following challenge with WNV. Also, the WN-80E/Alhydrogel formulations with or without GPI-0100 were well tolerated and elicited high neutralizing antibody (nAb) titers in rabbits. Cumulatively, because these findings demonstrated that the WN-80E formulated with Alhydrogel™ alone elicited robust antibody responses and protection against viral challenge, this formulation was selected for further evaluation in clinical trials for the prevention of WNV disease in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aluminum HydroxideWest Nile FeverWest Nile virusWest Nile Virus VaccinesAdjuvants, ImmunologicAdjuvants, VaccineAnimalsRabbitsFemaleMiceAntibodies, ViralVaccines, SubunitCricetinaeVaccines, SyntheticAntibodies, NeutralizingProtein Subunit VaccinesImmunogenicity, Vaccine

Substanzen

Aluminum HydroxideWest Nile Virus VaccinesAdjuvants, ImmunologicAntibodies, ViralVaccines, SubunitAdjuvants, VaccineVaccines, SyntheticAntibodies, NeutralizingProtein Subunit Vaccines

Autor:innen und Institutionen

  • University of Texas Medical Branch, Galveston, Texas, USA.
  • Hawaii Biotech Inc., Honolulu, Hawaii, USA.
  • Family Nurse Practitioners, Houston, Texas, USA.

Zitieren

APA

Watts, D. M., Coller, B. G., Da Rosa Travassos, A. P., Newman, P., Grant, A., Martyak, T., Jia, J., Clements, D. E., & Lieberman, M. M. (2026). Pre-Clinical Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine Formulated with Aluminum Hydroxide Adjuvant. The American Journal of Tropical Medicine and Hygiene, 115(2), 372-382. https://doi.org/10.4269/ajtmh.26-0133

Vancouver

Watts DM, Coller BG, Da Rosa Travassos AP, Newman P, Grant A, Martyak T, et al. Pre-Clinical Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine Formulated with Aluminum Hydroxide Adjuvant. The American Journal of Tropical Medicine and Hygiene. 2026;115(2):372-382. doi:10.4269/ajtmh.26-0133

BibTeX
@article{Watts2026,
  author = {Watts, Douglas M and Coller, Beth-Ann G and Da Rosa Travassos, Amelia P and Newman, Patrick and Grant, Ashley and Martyak, Timothy and Jia, Junhui and Clements, David E and Lieberman, Michael M},
  title = {Pre-Clinical Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine Formulated with Aluminum Hydroxide Adjuvant},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2026},
  volume = {115},
  number = {2},
  pages = {372--382},
  doi = {10.4269/ajtmh.26-0133}
}
Kostenlos starten →